help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pallas, K. G.
Right arrow Articles by Lucas, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pallas, K. G.
Right arrow Articles by Lucas, C. P.

Journal of Clinical Endocrinology & Metabolism, Vol 44, 1061-1068, Copyright © 1977 by Endocrine Society

ARTICLES

The effect of conjugated estrogens on the renin-angiotensin system

KG Pallas, GJ Holzwarth, MP Stern and CP Lucas

In a survey of 3 California communities by the Stanford Heart Disease Prevention Program, we obtained data on blood pressure, medications, age, height and weight, blood for measurement of plasma renin activity (PRA), plasma renin concentration (PRC), plasma renin reactivity (RR), and plasma renin substate concentration (PRS), and urine for measurement of urinary sodium and creatinine. No effect of conjugated estrogens (Premarin) on blood pressure could be discerned when the blood pressure, corrected for age and relative weight, of 575 women on no medication was compared to that of 82 women taking only Premarin. Premarin increased PRA, PRS, and RR, but had no effect on PRC. We also found in both Premarin-treated woman and controls 1) that RR was positively correlated with PRS, and 2) that PRA is dependent on PRC and PRS. These data indicate that the reninrenin substrate reaction of plasma, even at normal substrate concentration, is strongly deprendent on PRS.


This article has been cited by other articles:


Home page
 J. Physiol.Home page
E. G. Krause, K. S. Curtis, T. L. Stincic, J. P. Markle, and R. J. Contreras
Oestrogen and weight loss decrease isoproterenol-induced Fos immunoreactivity and angiotensin type 1 mRNA in the subfornical organ of female rats
J. Physiol., May 15, 2006; 573(1): 251 - 262.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
P. A. Komesaroff, M. Fullerton, M. D. Esler, A. Dart, G. Jennings, and K. Sudhir
Low-Dose Estrogen Supplementation Improves Vascular Function in Hypogonadal Men
Hypertension, November 1, 2001; 38(5): 1011 - 1016.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
K. Sudhir, M. D. Esler, G. L. Jennings, and P. A. Komesaroff
Estrogen Supplementation Decreases Norepinephrine-Induced Vasoconstriction and Total Body Norepinephrine Spillover in Perimenopausal Women
Hypertension, December 1, 1997; 30(6): 1538 - 1543.
[Abstract] [Full Text]

Home page
 HypertensionHome page
K. Sudhir, G. L. Jennings, J. W. Funder, and P. A. Komesaroff
Estrogen Enhances Basal Nitric Oxide Release in the Forearm Vasculature in Perimenopausal Women
Hypertension, September 1, 1996; 28(3): 330 - 334.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1977 by The Endocrine Society